Skip to main content

Table 2 Comparison of clinical parameters and Rad_score of the patients between recurrence and non-recurrence group

From: Clinical parameters combined with radiomics features of PET/CT can predict recurrence in patients with high-risk pediatric neuroblastoma

Factors

Recurrence

Non-recurrence

P

Gender

  

0.066

  Female

22 (43.1%)

21 (63.6%)

 

  Male

29 (56.9%)

12 (36.4%)

 

Age (years)

4.0 (2.8–5.7)

2.9 (2.1–4.3)

0.041

NSE (ng/mL)

430.0 (213.1–782.8)

275.0 (100.0–674.0)

0.093

Ferritin (ng/mL)

255.0 (120.8–366.6)

123.7 (63.7–251.9)

0.017

LDH (U/L)

727.0 (521.5–1122.5)

605.0 (359.0–1435.0)

0.731

VMA (µmol/L)

537.0 (188.1–716.0)

78.6 (28.9–194.6)

< 0.001

HVA (µmol/L)

92.8 (32.6–182.3)

45.5 (13.9–59.2)

0.002

Rad_score

0.75 (0.21–1.76)

−0.83 (−1.27–0.03)

< 0.001

HVA Homovanillic acid, LDH Lactate dehydrogenase, NSE Neuron-specific enolase, VMA Vanillylmandelic acid